Item 5.07.  Submission of Matters to a Vote of Security Holders.
On April 29, 2021, Inspire Medical Systems, Inc. (the "Company") held its annual
meeting of stockholders. A total of 24,974,586 shares of the Company's common
stock were present in person or represented by proxy at the meeting,
representing approximately 91.92% of the Company's common stock outstanding as
of the March 4, 2021 record date. Following are the voting results for the
proposals considered and voted upon at the meeting, each of which were described
in the Company's Definitive Proxy Statement filed with the Securities and
Exchange Commission (the "SEC") on March 16, 2021 (the "Definitive Proxy
Statement").
Item 1 - Election of Directors
The following Class III directors were elected for a term of office expiring on
the date of the Company's annual meeting of stockholders to be held in 2024 and
until their respective successors have been duly elected and qualified. The
number of votes cast for and withheld from each nominee and the number of broker
non-votes with respect to each nominee were as follows:
                               Votes FOR       Votes WITHHELD        Broker Non-Votes
Marilyn Carlson Nelson         14,160,883         8,048,786             2,764,917
Jerry C. Griffin, M.D.         15,206,728         7,002,941             2,764,917
Casey M. Tansey                16,899,075         5,310,594             2,764,917

Item 2 - Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for 2021 The Company's stockholders ratified the appointment by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021 by voting as follows:


 Votes FOR        Votes AGAINST       Votes ABSTAINED       Broker Non-Votes
 24,948,554           9,951               16,081                   -

Item 3 - Advisory Vote on Approval of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers by voting as follows:


 Votes FOR        Votes AGAINST       Votes ABSTAINED       Broker Non-Votes
 20,008,630         2,160,133             40,906               2,764,917





                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses